INDIANAPOLIS, Dec. 8, 2010 /PRNewswire/ -- BioStorage Technologies, a global leader in scientific asset management, cold chain logistics and biomaterial storage for the bioscience industry, has expanded its service offerings to include a suite of global sample relocation services. The addition of these services enhances the company’s global logistics capabilities and allows clients to customize transportation of entire sample inventories and associated equipment.
At the center of BioStorage Technologies’ relocation services is ReloFleet: the first mobile unit created specifically for sample relocation. The custom-made, 53-foot trailer accommodates storage temperatures from ambient to -20°C and is capable of transporting a multitude of biomaterial samples including plasma, blood and tissue samples, as well as active, pharmaceutical ingredients and manufactured drug products. Equipped with redundant generator systems, the unit also allows BioStorage Technologies to transport freezers, including liquid nitrogen and refrigerators intact and running.
“Sample logistics and transportation deficiencies are widely recognized as a primary cause of compromised biological samples, which renders them ineffective for testing and research,” said Lori A. Ball, chief operating officer, BioStorage Technologies. “By offering a comprehensive suite of relocation services, including superior cold chain transportation options, our clients can be assured that their scientific sample assets and equipment will reach its destination on time and in optimal condition.”
BioStorage Technologies’ specialized team of global logistics experts have extensive international experience, and can provide full-scale support through every phase of the transportation process, including point-to-point tracking, re-icing and real-time issue resolution. Additionally, the ReloFleet service provides sample tracking along the transportation process with a complete audit trail of sample movement from site to site.
BioStorage Technologies is also one of only a few biorepositories designated as a Certified Cargo Screening Facility (CCSF) by the U.S. Transportation Security Administration. This certification allows BioStorage Technologies to pre-screen shipments at its facility, thereby avoiding screening delays at the airport, which could lead to sample degradation.
BioStorage Technologies’ processes, systems and technology platforms are validated to adhere to U.S. Food and Drug Administration regulations, as well as U .S. Department of Transportation and International Air Transport Association guidelines.
About BioStorage Technologies, Inc.:
BioStorage Technologies, Inc. is the benchmark and global leader in centralized sample management and onsite solutions for the bioscience industry. Its expertise is in the management of the complete lifecycle of a research sample from the planning, collection, transportation and protection to sample retrieval and storage. The company offers highly qualified sample asset experts, best-in-class storage practices, real-time, web-based intelligence and tracking of research samples, as well as expertise in cold chain logistics and next-day retrieval and shipment of biomaterials. BioStorage Technologies, Inc. is privately held and headquartered in Indianapolis with an additional full-service site near Frankfurt, Germany. For more information, visit www.biostorage.com or call +1 (866) 697-2675 or +49-6155-898-1011.
Press Contact: | |
Michael Clark | |
Miller Brooks, Inc. | |
317-873-8100 | |
michael@millerbrooks.com | |
SOURCE BioStorage Technologies
